Edwards Lifesciences to spin off critical-care unit, sets $1B stock buyback
December 07, 2023 at 12:06 PM EST
Katie Szyman will be chief executive of the independent company, which is expected to generate $905 million in sales in 2023.
Photography by Christophe Tomatis